Analyst recommendations: Amazon.com, Mastercard, Bristol-Myers Squibb Company, Uber Technologies, Regeneron Pharmaceuticals...

November 01, 2024 at 08:39 am EDT

Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

Alnylam Pharmaceuticals: Citigroup maintains its buy recommendation with a price target reduced from USD 342 to USD 340.
Amazon.com: Goldman Sachs maintains its buy recommendation and raises the target price from USD 230 to USD 240.
Auto Trader Group: Deutsche Bank maintains its buy recommendation and raises the target price from 949 to GBX 1040.
Beazley: Peel Hunt maintains its add recommendation and raises the target price from GBX 750 to GBX 840.
Bristol-Myers Squibb Company: Goldman Sachs maintains its buy recommendation and raises the target price from USD 60 to USD 62.
Cf Industries Holdings: JP Morgan maintains its neutral recommendation and raises the target price from 76 to USD 82.
Estee Lauder: JP Morgan downgrades to neutral from overweight with a target price reduced from USD 113 to USD 74.
Fox Corporation: Morgan Stanley maintains its market weight recommendation and raises the target price from 38 to USD 40.
Generac Holdings: JP Morgan maintains its neutral recommendation and raises the target price from 178 to USD 180.
Gsk: Goldman Sachs maintains a neutral recommendation with a price target reduced from 1800 to GBX 1690.
Iqvia Holdings: Citigroup remains neutral with a price target reduced from USD 250 to USD 225.
Linde: Deutsche Bank maintains its buy recommendation and raises the target price from USD 510 to USD 515.
Mastercard: Punto Research maintains its buy recommendation and raises the target price from 541 to USD 564.25.
Ptc: Berenberg downgrades to hold from buy with a target price reduced from USD 210 to USD 196.
Quanta Services: B Riley Securities maintains its buy recommendation with a price target reduced from USD 343 to USD 335.
Regeneron Pharmaceuticals: Bernstein maintains its outperform recommendation and reduces the target price from USD 1135 to USD 1110.
Teleflex: Raymond James maintains its outperform rating and reduces the target price from USD 266 to USD 245.
Uber Technologies: Punto Research maintains its buy recommendation and raises the target price from USD 85.11 to USD 88.28.
Vontier Corporation: Citigroup maintains its buy recommendation with a price target raised from USD 40 to USD 44.
Watts Water Technologies: Goldman Sachs maintains a neutral recommendation with a price target raised from 195 to USD 197.
Zimmer Biomet Holdings: Goldman Sachs maintains its neutral recommendation with a price target raised from 116 to USD 118.

Grégoire Legrand

Analyst

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
REGENERON PHARMACEUTICALS, INC.	754.26USD	+0.63%	-0.08%	81.15B
VONTIER CORPORATION	39.08USD	+0.39%	-0.26%	5.87B
BRISTOL-MYERS SQUIBB COMPANY	58.37USD	-0.55%	-1.52%	118B
CF INDUSTRIES HOLDINGS, INC.	91.50USD	-2.80%	+3.20%	15.92B
ESTEE LAUDER	79.29USD	+2.34%	+7.21%	28.46B
PTC INC.	201.19USD	+0.49%	+1.10%	24.17B
AMAZON.COM, INC.	218.16USD	+2.21%	+6.04%	2,294B
QUANTA SERVICES, INC.	333.66USD	-1.79%	-2.99%	49.25B
TELEFLEX INCORPORATED	187.33USD	-0.43%	-2.43%	8.7B
WATTS WATER TECHNOLOGIES, INC.	216.20USD	+1.08%	+0.52%	7.21B
ZIMMER BIOMET HOLDINGS, INC.	110.62USD	-0.11%	-1.25%	22.02B
MASTERCARD, INC.	521.14USD	-0.96%	-2.11%	478B
AUTO TRADER GROUP PLC	844.00GBX	+0.57%	+0.96%	9.57B
BEAZLEY PLC	806.00GBX	+2.28%	+5.08%	6.45B
IQVIA HOLDINGS INC.	203.17USD	+1.29%	+0.86%	36.88B
LINDE PLC	459.45USD	+0.29%	+0.51%	219B
FOX CORPORATION	46.30USD	-0.24%	-0.88%	20.61B
UBER TECHNOLOGIES, INC.	72.16USD	+1.25%	+0.75%	152B
GENERAC HOLDINGS, INC.	182.57USD	-2.30%	-4.11%	10.86B
ALNYLAM PHARMACEUTICALS, INC.	254.72USD	+1.14%	+0.39%	32.85B
GSK PLC	1,355.00GBX	-0.95%	+0.82%	70.3B

All News: More news

Orkla ASA: Status share buyback programme	02:03am	AQ
Safran sets course for higher revenue, profit by 2028	02:02am	RE
Moonpig Group Plc - Transaction in Own Shares	02:02am	PR
FirstGroup Plc - Transaction in Own Shares	02:02am	PR
FirstGroup Plc - Open access rail acquisition and new services application	02:02am	PR
Anglesey Mining Plc - Board Changes	02:02am	PR
BlackRock Frontiers Investment Trust Plc - Final Results	02:02am	PR
Bodycote Plc - Transaction in Own Shares	02:02am	PR
Hoa Phat : supplies over 5,000 tons of high-quality construction steel for the US Embassy complex in Hanoi	02:02am	PU
Announcement regarding situation for acquisition of own shares [PDF:177KB]	02:02am	PU
Safran : 2024 Capital Markets Day (CMD’24) - Safran is poised to deliver a further period of profitable growth	02:02am	PU
Catella : APAM Completed 10-Year Lease to TJ Hughes at The Mander Centre, Wolverhampton	02:02am	PU
Custodian Property Income REIT plc: Interim Results	02:02am	EQ
Qliro launches a new consumer app in Norway	02:01am	AQ
HAV Group ASA: Subsidiary to deliver charging stations to Lavik-Oppedal ferries	02:01am	AQ